Thrombectomy Clinical Trials

Clinical trials related to Thrombectomy Procedure

FORWARD: Functional Outcomes in Real-World Treatment And Revascularization of Non-dominant and Distal M2 Occlusions

Status: Recruiting
Location: See all (5) locations...
Intervention Type: Device, Other
Study Type: Observational
SUMMARY

The objective of this study is to collect safety and effectiveness data on the Penumbra System reperfusion catheters in participants with isolated primary non-dominant and distal M2 occlusions who undergo endovascular mechanical thrombectomy (EVT). Additionally, this study aims to observe characteristics and outcomes of participants treated with medical management (MM) alone and those who receive EVT + MM per current medical practice.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Participant age ≥ 18

• Participant experiencing acute ischemic stroke due to a confirmed primary M2 occlusion in the vertical segment or post-bifurcation in the non-dominant or co-dominant branch of the horizontal segment

• NIHSS ≥5 or NIHSS 3-4 with disabling symptoms

• Pre-stroke mRS 0-1

• For participants undergoing thrombectomy: Planned first-line treatment with Penumbra System reperfusion catheters

• Informed consent obtained per Institutional Review Board/Ethics Committee requirements

Locations
United States
Colorado
Swedish Medical Center
RECRUITING
Englewood
Connecticut
Yale New Haven Hospital
RECRUITING
New Haven
Kentucky
University of Kentucky
RECRUITING
Lexington
Tennessee
Fort Sanders Regional Medical Center
RECRUITING
Knoxville
Semmes Murphey
RECRUITING
Memphis
Contact Information
Primary
Madeline Turtle
MTurtle@PENUMBRAINC.COM
260-224-8231
Backup
Jennifer Jelf
jjelf@penumbrainc.com
510-440-5719
Time Frame
Start Date: 2026-06-26
Estimated Completion Date: 2028-09
Participants
Target number of participants: 250
Treatments
Medical Management
Endovascular Thrombectomy plus Medical Management
Related Therapeutic Areas
Sponsors
Leads: Penumbra Inc.

This content was sourced from clinicaltrials.gov